← Back to patent-cliff list
Apomorphine(Grupo Ferrer Internacional)
Tier C — Watch / tradeApomorphine(Grupo Ferrer Internacional)
Grupo Ferrer Internacional Sa
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：DRDs
Brand：Apomorphine Staccato
Indications (approved)：Parkinson's disease
Regional status
US
-
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Apomorphine(Grupo Ferrer Internacional)?
Approved indications include: Parkinson's disease.
When does the Apomorphine(Grupo Ferrer Internacional) patent expire?
No public expiry year is available for Apomorphine(Grupo Ferrer Internacional) yet; this page updates once verified.
How do I get a quote for Apomorphine(Grupo Ferrer Internacional) intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-01